Haryana has halted production at Maiden Pharmaceuticals' Sonipat plant after the World Health Organization (WHO) last week said cough syrups produced made by the company could be linked to the deaths of 66 children in Gambia.
News agency ANI quoted health minister Anil Vij as saying that while laboratory reports of the samples collected from the company are awaited, the state had decided to halt total production at the plant. A joint inspection by the state Food and Drugs Administration and Central Drugs Standard Control Organisation (CDSCO) found 12 violations of good manufacturing practices in the Sonipat facility, he said.